Rapid Update 2- February 2018: Biochemical monitoring: UK observational study in people taking an aldosterone antagonist finds many are not monitored in line with guidelines

This content is available to authorised users working in organisations that subscribe to ScriptSwitch only. Authorised users need to be logged in to read this content.

Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.

Rapid Update 2 – February 2017: Under-implementation of guidance on monitoring of creatinine and potassium in those taking ACE inhibitors or ARBs

This content is available to authorised users working in organisations that subscribe to ScriptSwitch only. Authorised users need to be logged in to read this content.

Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.

Blood pressure lowering in people with intermediate risk without cardiovascular disease: antihypertensive results from the HOPE-3 trial (Jul-16)

This content is available to authorised users working in organisations that subscribe to ScriptSwitch only. Authorised users need to be logged in to read this content.

Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.

Hypertension: Lowering blood pressure can work whatever the blood pressure (Feb-16)

This content is available to authorised users working in organisations that subscribe to ScriptSwitch only. Authorised users need to be logged in to read this content.

Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.

NPC Archive Item: Review aliskiren▼ prescriptions following MHRA safety warning

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. Aliskiren: risk of cardiovascular and renal adverse reactions — new contraindications and warnings The combination of aliskiren with ACE inhibitors or angiotensin receptor blockers (ARBs) has been associated with […]